[{"address1": "3580 CARMEL MOUNTAIN ROAD", "address2": "SUITE 200", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 727 1040", "website": "https://www.connectbiopharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.", "fullTimeEmployees": 62, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barry D. Quart Pharm.D.", "age": 67, "title": "CEO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 547466, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David L. Szekeres J.D.", "age": 50, "title": "President", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 409305, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Peraza CPA", "age": 47, "title": "Senior Vice President of Finance", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 210889, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeff  Cohn J.D.", "age": 42, "title": "General Counsel & Corporate Secretary", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sean T. Ristine", "age": 54, "title": "Vice President of Human Resources", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lei  Sun Ph.D.", "age": 60, "title": "VP of Biologics & Head of CMC", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Srikanth  Pendyala M.D.", "title": "Senior Vice President of Clinical Development(Consultant)", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kimberly J. Manhard", "age": 64, "title": "Executive VP & Chief Development Officer", "yearBorn": 1960, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.63, "open": 1.6361, "dayLow": 1.56, "dayHigh": 1.69, "regularMarketPreviousClose": 1.63, "regularMarketOpen": 1.6361, "regularMarketDayLow": 1.56, "regularMarketDayHigh": 1.69, "payoutRatio": 0.0, "beta": -0.083, "forwardPE": -7.7999997, "volume": 177038, "regularMarketVolume": 177038, "averageVolume": 184058, "averageVolume10days": 192180, "averageDailyVolume10Day": 192180, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 86925848, "fiftyTwoWeekLow": 0.51, "fiftyTwoWeekHigh": 2.86, "priceToSalesTrailing12Months": 44.237072, "fiftyDayAverage": 1.84266, "twoHundredDayAverage": 1.136515, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 16027785, "profitMargins": 0.0, "floatShares": 14343869, "sharesOutstanding": 55721700, "heldPercentInsiders": 0.40535, "heldPercentInstitutions": 0.44242, "impliedSharesOutstanding": 55721700, "bookValue": 1.284, "priceToBook": 1.2149532, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -44953000, "trailingEps": -0.81, "forwardEps": -0.2, "enterpriseToRevenue": 8.157, "enterpriseToEbitda": -0.327, "52WeekChange": 0.32203388, "SandP52WeekChange": 0.16885936, "quoteType": "EQUITY", "currentPrice": 1.56, "targetHighPrice": 7.5, "targetLowPrice": 6.0, "targetMeanPrice": 6.83333, "targetMedianPrice": 7.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 71768000, "totalCashPerShare": 1.288, "ebitda": -49058000, "totalDebt": 870000, "quickRatio": 6.7, "currentRatio": 7.239, "totalRevenue": 1965000, "debtToEquity": 1.219, "revenuePerShare": 0.035, "returnOnAssets": -0.30581, "returnOnEquity": -0.49448, "grossProfits": 1965000, "freeCashflow": -25247000, "operatingCashflow": -37876000, "revenueGrowth": -0.998, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -279.6667, "financialCurrency": "USD", "symbol": "CNTB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Connect Biopharma Holdings Limi", "longName": "Connect Biopharma Holdings Limited", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616160600000, "postMarketChangePercent": -0.338596, "postMarketPrice": 1.56, "postMarketChange": -0.00530005, "regularMarketChange": -0.07000005, "regularMarketDayRange": "1.56 - 1.69", "fullExchangeName": "NasdaqGM", "corporateActions": [], "postMarketTime": 1757707803, "regularMarketTime": 1757707200, "exchange": "NGM", "messageBoardId": "finmb_706016439", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.2944818, "regularMarketPrice": 1.56, "marketState": "CLOSED", "averageDailyVolume3Month": 184058, "fiftyTwoWeekLowChange": 1.05, "fiftyTwoWeekLowChangePercent": 2.0588236, "fiftyTwoWeekRange": "0.51 - 2.86", "fiftyTwoWeekHighChange": -1.3, "fiftyTwoWeekHighChangePercent": -0.45454547, "fiftyTwoWeekChangePercent": 32.20339, "earningsTimestampStart": 1757069940, "earningsTimestampEnd": 1758283200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.81, "epsForward": -0.2, "epsCurrentYear": -0.92, "priceEpsCurrentYear": -1.6956521, "fiftyDayAverageChange": -0.28266, "fiftyDayAverageChangePercent": -0.15339781, "twoHundredDayAverageChange": 0.42348492, "twoHundredDayAverageChangePercent": 0.3726171, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-19", "averageAnalystRating": "1.3 - Strong Buy", "displayName": "Connect Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-09-13"}]